SAS (ASX) SAS allegedly laying off many staff at London office

Originally posted by kingy: ↑

very interesting discussion regarding renumeration...it reflects why sensei anies ect have been so keen to downplay the achievements so far ...why it is so important to discredit any positive announcement ...to the point of being negative on an announcement without even reading it...(note sensei and vig)...included in the negativity has been referring to actual achievements in forward looking statement disclaimers to undermine the result and trivialising the value of the 30 or so agreements so far
the fact is that the management are about to commercialize world first technology which if successful will lead to exponential commercial growth...so far they have successfully completed voice and text messaging secure banking spectrum monitoring testing and are about to launch the real deal
all this using their unique software which manages the constellation
not only that but the will only need one ground station and a backup
these guys arnt 2 uni students developing an app ...they are about to commercialize massive infrastructure and very few on the planet have the skill set and gumption to achieve what they have done so far...and what they about to achieve....it makes it much easier to criticize the renumeration when you have trivialised what has already been achieved
as always
dyor
always read announcements entirely
don't misquote the disclaimer

Expand

The current SP is reflection of what they have achieved so far. Its hovering to 52 week low, and more importantly below the last CR price of 3c which of itself is heavily discounted. Further, there seems no be no bounce from this level.

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NAM

The current SP is reflection of what they have achieved so far....

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Featured News

The current SP is reflection of what they have achieved so far....

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Featured News